"Sequential triple-T" therapy for CLL
Novel PD-1 inhibitor and BTK inhibitor combination: tislelizumab and zanubrutinib
What are the challenges of allogeneic stem cell transplant in myeloma?
Results of the ASPIRE trial for MM: the addition of carfilzomib
Follow-up CAR T-cell data so far